A multiple-array SPRi biosensor has been developed for the simultaneous determination of CA125, HE4, CEA, IL-6 and aromatase, which are useful in the diagnostics of oncological and gynecological diseases. Here, CEACAM5 is linked to female reproductive system disorder.